The American Society of Tropical Medicine and Hygiene (ASTMH) assisted with publication expenses.
Brett-Major DM, Racine T, Kobinger GP, 2019. Consequences of pathogen lists: why some diseases may continue to plague us. Am J Trop Med Hyg 100: 1052–1055.
Fedson DS, 2017. Clinician-initiated research on treating the host response to pandemic influenza. Hum Vaccin Immunother 14: 790–795.
Wong G, Mendoza EJ, Plummer FA, Gao GF, Kobinger GP, Qiu X, 2018. From bench to almost bedside: the long road to a licensed Ebola virus vaccine. Expert Opin Biol Ther 18: 159–173.
Pirofski LA, Casadevall A, 2018. The damage-response framework as a tool for the physician-scientist to understand the pathogenesis of infectious diseases. J Infect Dis 218 (Suppl 1): S7–S11.
Fedson DS, 2016. Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola. Ann Transl Med 4: 421.
Parihar SP, Guler R, Brombacher F, 2018. Statins: a viable candidate for host-directed therapy against infectious diseases. Nat Rev Immunol 19: 104–117.
Binder HJ, Brown I, Ramakrishna BS, Young GP, 2014. Oral rehydration therapy in the second decade of the twenty-first century. Curr Gastroenterol Rep 16: 376.
Caffrey AR, Timbrook TT, Noh E, Sakoulas G, Opal SM, Nizet V, LaPlante KL, 2017. Evidence to support continuation of statin therapy in patients with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 61: e02228-16.